SCHEMBL6714191

SCHEMBL6714191

O=C(Cc1ccc(Cl)c(Cl)c1)Nc1cccc2cc(C(=O)Nc3ccc(Cl)cc3-c3nnn[nH]3)[nH]c12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP14 Q460N5 2/20 0.45
TRPV1 Q8NER1 2/20 0.42
KDM4E B2RXH2 1/20 0.40
MAPT P10636 1/20 0.40
CLK1 P49759 1/20 0.40
KCNQ2 O43526 1/20 0.37
PLCG2 P16885 1/20 0.36
POLB P06746 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
LMNA P02545 2/20 0.36
GAA P10253 1/20 0.36
MCOLN3 Q8TDD5 1/20 0.36
MAOB P27338 1/20 0.35
F10 P00742 1/20 0.35
NHERF1 O14745 2/20 0.35
TP53 P04637 1/20 0.35
RORC P51449 1/20 0.35
CDK1 P06493 1/20 0.34
CCNA2 P20248 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6707755 0.94 PARP14 (0.43) PARP14KDM4EPLCG2POLBMEN1
SCHEMBL6712041 0.93 LMNA (0.41) PARP14KCNQ2PLCG2POLBMEN1
SCHEMBL6707957 0.92 PARP14 (0.44) PARP14TRPV1KDM4EMAPTCLK1
SCHEMBL6714087 0.92 NPY5R (0.42) PARP14TRPV1PLCG2POLBMEN1
SCHEMBL6708820 0.91 PARP14 (0.41) PARP14KDM4EPLCG2POLBMEN1
SCHEMBL6708944 0.91 PARP14 (0.39) PARP14MAPTPLCG2POLBMEN1
SCHEMBL6709152 0.91 PTK2B (0.42) PARP14KDM4EMAPTPLCG2MEN1
SCHEMBL6711435 0.90 PARP14 (0.42) PARP14TRPV1KDM4EMAPTCLK1
SCHEMBL6713211 0.90 PARP14 (0.42) PARP14KDM4EPOLBMEN1KMT2A
SCHEMBL6709118 0.90 PTK2B (0.40) PARP14KDM4EKCNQ2PLCG2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 PARP14 2597/4885TRPV1 1338/4885KDM4E 1582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.